摘要:
The invention relates to a triazole derivative with an activity inhibiting glycine transporter and for use as a pharmaceutical drug, and a novel triazole derivative. The inventive triazole derivative has an excellent activity inhibiting glycine transporter and is useful as a therapeutic agent of dementia, schizophrenia, cognitive disorders, or cognitive disorders involved in various diseases such as Alzheimer disease, Parkinson's disease, or Huntington disease or the like, or spasm involved in diseases such as nerve degenerative diseases and cerebrovascular disorders, or the like. Particularly, the pharmaceutical drug is useful for the amelioration of learning disability of dementia and the like.
摘要:
The invention relates to formula (1) heterocyclic aminoalkyl pyridine derivatives, whereby R1 represents the radical of a heterocycle comprising 1 to 3 ring structures which are saturated, unsaturated or aromatic and optionally annellated with other ring structures to form a condensed ring system, and which comprise a total of 1 to 4 N-, O- and/or S-atoms, said heterocycle being optionally substituted once, twice or three times by at least one of the following groups: -A, -OR?4, -N(R4)¿2, -NO2, -CN, Hal, -COOR4, -CON(R4)2, -COR4, = O; R2 represents a phenyl group which is optionally substituted once, twice, three, four or five times by at least one of the following groups: Hal, A, -O-A, -NO¿2? or CN, or a thienyl group which is optionally substituted once or twice by at least one of the following groups: Hal, A, -O-A, -NO2, -CN or thienyl; -X- represents -O-, -S-, sulfinyl, sulfonyl, or -C(R?4)¿2-; -Y- represents -[C(R4)2]n-; -Z- represents -C(R4)2-; and n represents 1, 2, 3 or 4. The invention also relates to the compatible salts and solvates of the heterocyclic aminoalkyl pyridine derivatives and the use thereof as pharmaceuticals.
摘要:
The invention relates to compounds of formula (I), in addition to their salts and solvates. In said formula, X, R1, R2, R3, R4 and R5 are defined as cited in claim (1). Said compounds are suitable for use as ligands of 5 HT receptors.
摘要:
The invention relates to the compounds of formula (I) and the salts and solvates thereof, wherein X, R1, R2, R3, R4 and R5 are defined as in claim 1. The inventive compounds are suitable as ligands of 5 HT receptors.
摘要:
The invention relates to inhibitors of the glycine cleavage system and their use as potential antipsychotic agents. The invention relates furthermore to a process for treating humans having psychosis, psychosis associated with an illness, schizophrenia, Alzheimer's disease or other related psychotic disorders.
摘要:
Piperazine derivatives having formula (I), wherein R?1 and R2¿ have the meanings given in claim 1, are dopamine ligands with D4 receptor selectivity and are suited for treatment and prophylaxis of anxiety states, depression, schizophrenia, obsessive ideas, Parkinson's disease, tardive diskinesia, nausea and gastro-intestinal tract disorders.
摘要:
The invention relates to formula (1) heterocyclic aminoalkyl pyridine derivatives, whereby R1 represents the radical of a heterocycle comprising 1 to 3 ring structures which are saturated, unsaturated or aromatic and optionally annellated with other ring structures to form a condensed ring system, and which comprise a total of 1 to 4 N-, O- and/or S-atoms, said heterocycle being optionally substituted once, twice or three times by at least one of the following groups: -A, -OR?4, -N(R4)¿2, -NO2, -CN, Hal, -COOR4, -CON(R4)2, -COR4, = O; R2 represents a phenyl group which is optionally substituted once, twice, three, four or five times by at least one of the following groups: Hal, A, -O-A, -NO¿2? or CN, or a thienyl group which is optionally substituted once or twice by at least one of the following groups: Hal, A, -O-A, -NO2, -CN or thienyl; -X- represents -O-, -S-, sulfinyl, sulfonyl, or -C(R?4)¿2-; -Y- represents -[C(R4)2]n-; -Z- represents -C(R4)2-; and n represents 1, 2, 3 or 4. The invention also relates to the compatible salts and solvates of the heterocyclic aminoalkyl pyridine derivatives and the use thereof as pharmaceuticals.
摘要:
The invention relates to compounds of formula (I), in addition to their salts and solvates. In said formula, X, R1, R2, R3, R4 and R5 are defined as cited in claim (1). Said compounds are suitable for use as ligands of 5 HT receptors.